Failure to Recognize Novelty after Extended Methamphetamine Self-Administration Results from Loss of Long-Term Depression in the Perirhinal Cortex
Exposure to methamphetamine (meth) can produce lasting memory impairments in humans and rodents. We recently demonstrated that extended access meth self-administration results in novel object recognition (NOR) memory deficits in rats. Recognition of novelty depends upon intact perirhinal (pRh) corte...
Saved in:
Published in | Neuropsychopharmacology (New York, N.Y.) Vol. 40; no. 11; pp. 2526 - 2535 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Nature Publishing Group
01.10.2015
|
Subjects | |
Online Access | Get full text |
ISSN | 0893-133X 1740-634X |
DOI | 10.1038/npp.2015.99 |
Cover
Abstract | Exposure to methamphetamine (meth) can produce lasting memory impairments in humans and rodents. We recently demonstrated that extended access meth self-administration results in novel object recognition (NOR) memory deficits in rats. Recognition of novelty depends upon intact perirhinal (pRh) cortex function, which is compromised by meth-induced downregulation of GluN2B-containing N-methyl-D-aspartate (NMDA) receptors. NMDA receptors containing this subunit have a critical role in pRh long-term depression (LTD), one of the primary physiological processes thought to underlie object recognition memory. We hypothesized that meth-induced downregulation of GluN2B receptors would compromise pRh LTD, leading to loss of NOR memory. We found that meth self-administration resulted in an inability to induce pRh LTD following 1 Hz stimulation, an effect that was reversed with bath application of the NMDA receptor partial agonist D-cycloserine (DCS). In addition, pRh microinfusion of DCS restored meth-induced memory deficits. Furthermore, blockade of GluN2B-containing NMDA receptors with Ro 25-6981 prevented DCS restoration of pRh LTD in meth subjects. Thus, targeting pRh LTD may be a promising strategy to treat meth-induced cognitive impairment. |
---|---|
AbstractList | Exposure to methamphetamine (meth) can produce lasting memory impairments in humans and rodents. We recently demonstrated that extended access meth self-administration results in novel object recognition (NOR) memory deficits in rats. Recognition of novelty depends upon intact perirhinal (pRh) cortex function, which is compromised by meth-induced downregulation of GluN2B-containing N-methyl-
D
-aspartate (NMDA) receptors. NMDA receptors containing this subunit have a critical role in pRh long-term depression (LTD), one of the primary physiological processes thought to underlie object recognition memory. We hypothesized that meth-induced downregulation of GluN2B receptors would compromise pRh LTD, leading to loss of NOR memory. We found that meth self-administration resulted in an inability to induce pRh LTD following 1 Hz stimulation, an effect that was reversed with bath application of the NMDA receptor partial agonist D-cycloserine (DCS). In addition, pRh microinfusion of DCS restored meth-induced memory deficits. Furthermore, blockade of GluN2B-containing NMDA receptors with Ro 25-6981 prevented DCS restoration of pRh LTD in meth subjects. Thus, targeting pRh LTD may be a promising strategy to treat meth-induced cognitive impairment. Exposure to methamphetamine (meth) can produce lasting memory impairments in humans and rodents. We recently demonstrated that extended access meth self-administration results in novel object recognition (NOR) memory deficits in rats. Recognition of novelty depends upon intact perirhinal (pRh) cortex function, which is compromised by meth-induced downregulation of GluN2B-containing N-methyl-D-aspartate (NMDA) receptors. NMDA receptors containing this subunit have a critical role in pRh long-term depression (LTD), one of the primary physiological processes thought to underlie object recognition memory. We hypothesized that meth-induced downregulation of GluN2B receptors would compromise pRh LTD, leading to loss of NOR memory. We found that meth self-administration resulted in an inability to induce pRh LTD following 1 Hz stimulation, an effect that was reversed with bath application of the NMDA receptor partial agonist D-cycloserine (DCS). In addition, pRh microinfusion of DCS restored meth-induced memory deficits. Furthermore, blockade of GluN2B-containing NMDA receptors with Ro 25-6981 prevented DCS restoration of pRh LTD in meth subjects. Thus, targeting pRh LTD may be a promising strategy to treat meth-induced cognitive impairment. |
Author | Scofield, Michael D Reichel, Carmela M Schwendt, Marek Leong, Kah-Chung Peters, Jamie Trantham-Davidson, Heather See, Ronald E |
Author_xml | – sequence: 1 givenname: Michael D surname: Scofield fullname: Scofield, Michael D – sequence: 2 givenname: Heather surname: Trantham-Davidson fullname: Trantham-Davidson, Heather – sequence: 3 givenname: Marek surname: Schwendt fullname: Schwendt, Marek – sequence: 4 givenname: Kah-Chung surname: Leong fullname: Leong, Kah-Chung – sequence: 5 givenname: Jamie surname: Peters fullname: Peters, Jamie – sequence: 6 givenname: Ronald E surname: See fullname: See, Ronald E – sequence: 7 givenname: Carmela M surname: Reichel fullname: Reichel, Carmela M |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25865928$$D View this record in MEDLINE/PubMed |
BookMark | eNptkl1rFDEUhoNU7Hb1ynsJeCPIrMlkZya5EcraqrB-oBV6FzKZM7spmWRMMqX1Z_iLzdhWtHh1Auc5b97zcYQOnHeA0FNKVpQw_sqN46oktFoJ8QAtaLMmRc3W5wdoQbhgBWXs_BAdxXhBMtTU_BE6LCteV6LkC_TzVBk7BcDJ4y-g_c6ZH4A_-kuw6RqrPkHAJ1cJXAcd_gBpr4ZxD0kNxgH-CrYvjrv8NjEFlYx3WSRONkXcBz_grY8R-z5HtyvOIAz4DYwBYpxJ43DaA_4MwYS9ccrijQ8Jrh6jh72yEZ7cxiX6dnpytnlXbD-9fb853ha6angqOIG2pWWvy74mjDYaWkKhLUsmVNewjtXVWvFG1T3ouqRV1XUtEa2qSN1WOueX6PWN7ji1A3QaXO7ByjGYQYVr6ZWR_2ac2cudv5TrqhYi_7lEL24Fgv8-QUxyMFGDtcqBn6KkTVnSumFkRp_fQy_8FHLPM0WJ4JxQmqlnfzv6Y-VuXRmgN4AOebIBeqlN-j33bNBYSYmcT0Lmk5DzSUghcs3LezV3sv-jfwG-Druj |
CODEN | NEROEW |
CitedBy_id | crossref_primary_10_1007_s00429_016_1322_x crossref_primary_10_1016_j_neuroscience_2019_03_040 crossref_primary_10_1016_j_addicn_2024_100181 crossref_primary_10_1038_npp_2015_283 crossref_primary_10_1371_journal_pone_0218934 crossref_primary_10_1016_j_pbb_2020_173058 crossref_primary_10_1111_ejn_13159 crossref_primary_10_1016_j_neubiorev_2016_07_020 crossref_primary_10_1016_j_nlm_2021_107464 crossref_primary_10_1038_s41386_022_01371_9 crossref_primary_10_1016_j_neuropharm_2023_109711 crossref_primary_10_1101_lm_046797_117 crossref_primary_10_1111_adb_12881 crossref_primary_10_3390_brainsci14030258 crossref_primary_10_1124_jpet_116_238501 crossref_primary_10_1101_lm_048488_118 crossref_primary_10_1016_j_pbb_2018_09_007 crossref_primary_10_1016_j_pharmthera_2021_107831 crossref_primary_10_1007_s10571_023_01323_x crossref_primary_10_1007_s12272_017_0897_y crossref_primary_10_1016_j_neuropharm_2017_11_034 crossref_primary_10_1155_2017_7903918 |
Cites_doi | 10.1016/j.biopsych.2011.10.024 10.1007/s00213-010-1828-5 10.1038/nn1713 10.1016/j.neuropharm.2013.04.013 10.1073/pnas.0607973103 10.1038/npp.2011.276 10.1038/nn.3154 10.1523/JNEUROSCI.5289-06.2007 10.1038/npp.2012.179 10.1038/81823 10.1016/j.bbr.2009.12.036 10.1016/S0022-3565(24)37138-1 10.1016/j.jsat.2009.03.004 10.1016/j.neuron.2008.04.006 10.1523/JNEUROSCI.4447-07.2008 10.1016/j.neuron.2008.02.022 10.1038/nrn2572 10.1038/35049064 10.1038/72093 10.1038/nn1914 10.1038/nn.2250 10.1002/hipo.20178 10.1523/JNEUROSCI.0623-13.2014 10.1523/JNEUROSCI.1697-04.2004 10.1523/JNEUROSCI.1935-08.2008 10.1523/JNEUROSCI.6413-10.2011 10.1002/hipo.10049 10.1523/JNEUROSCI.4307-14.2015 10.1037/a0013829 10.1007/s11065-007-9031-0 10.1038/nn.2300 10.1111/adb.12061 10.1007/s00213-008-1187-7 10.1016/S0306-4522(98)00764-7 10.1371/journal.pone.0034299 10.1016/j.pneurobio.2011.03.002 10.1016/j.tins.2012.05.006 10.1002/syn.20471 10.1016/j.jsat.2004.03.011 10.1523/JNEUROSCI.5239-10.2011 10.1016/j.drugalcdep.2013.09.018 10.1016/j.neuropharm.2011.11.003 10.1038/npp.2010.212 10.1124/pr.112.007054 |
ContentType | Journal Article |
Copyright | Copyright Nature Publishing Group Oct 2015 Copyright © 2015 American College of Neuropsychopharmacology 2015 American College of Neuropsychopharmacology |
Copyright_xml | – notice: Copyright Nature Publishing Group Oct 2015 – notice: Copyright © 2015 American College of Neuropsychopharmacology 2015 American College of Neuropsychopharmacology |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7TK 7X7 7XB 88E 88G 8AO 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2M M7P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PSYQQ Q9U 5PM |
DOI | 10.1038/npp.2015.99 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) ProQuest Pharma Collection ProQuest SciTech Collection ProQuest Natural Science Journals ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Psychology Database (Proquest) Biological Science Database ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Psychology ProQuest Central Basic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Psychology ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Psychology Journals (Alumni) Biological Science Database ProQuest SciTech Collection Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest Psychology Journals ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) |
DatabaseTitleList | ProQuest One Psychology MEDLINE Neurosciences Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology Pharmacy, Therapeutics, & Pharmacology |
DocumentTitleAlternate | Novelty after extended methamphetamine |
EISSN | 1740-634X |
EndPage | 2535 |
ExternalDocumentID | PMC4569960 3803743581 25865928 10_1038_npp_2015_99 |
Genre | Journal Article Research Support, N.I.H., Extramural |
GeographicLocations | United States--US |
GeographicLocations_xml | – name: United States--US |
GrantInformation_xml | – fundername: NIDA NIH HHS grantid: DA007288 – fundername: NIDA NIH HHS grantid: T32 DA007288 – fundername: NIDA NIH HHS grantid: DA033049 – fundername: NCRR NIH HHS grantid: C06 RR015455 – fundername: NIDA NIH HHS grantid: R01 DA033049 |
GroupedDBID | --- -DZ -Q- 0R~ 29N 2WC 36B 39C 4.4 406 5RE 70F 7X7 88E 8AO 8FI 8FJ 8R4 8R5 AACDK AANZL AASML AATNV AAYXX AAYZH ABAKF ABBRH ABDBE ABFSG ABIVO ABJNI ABLJU ABUWG ABZZP ACAOD ACGFO ACGFS ACKTT ACMFV ACMJI ACPRK ACRQY ACSTC ACZOJ ADBBV ADFRT AEFQL AEJRE AEMSY AENEX AESKC AEVLU AEXYK AEZWR AFBBN AFDZB AFHIU AFKRA AFRAH AFSHS AGAYW AGHAI AGQEE AHMBA AHSBF AHWEU AIGIU AILAN AIXLP AJRNO ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS AMYLF AOIJS ASPBG ATHPR AVWKF AYFIA AZFZN AZQEC BAWUL BBNVY BENPR BHPHI BPHCQ BVXVI CCPQU CITATION CS3 DIK DNIVK DPUIP DWQXO E3Z EBLON EBS EE. EIOEI EJD EMB EMOBN F5P FDB FDQFY FERAY FIGPU FIZPM FSGXE FYUFA GNUQQ GX1 HCIFZ HMCUK HYE HZ~ IWAJR JSO JZLTJ KQ8 M1P M2M M7P MK0 NQJWS O9- OK1 P2P P6G PHGZM PHGZT PQQKQ PROAC PSQYO PSYQQ Q2X RNT RNTTT ROL RPM SNX SNYQT SOHCF SOJ SRMVM SV3 SWTZT TAOOD TBHMF TDRGL TR2 UKHRP W2D ZGI --K 1B1 53G 5VS AAEDT AALRI AAQFI AAQXK AAXUO ABMAC ABWVN ACIUM ACRPL ADMUD ADNMO CAG CGR COF CUY CVF ECM EIF FEDTE FGOYB HVGLF IHE LGEZI LOTEE M41 NADUK NPM NQ- NXXTH R2- RIG RNS RPZ SEW SSZ ZKB 3V. 7TK 7XB 8FE 8FH 8FK ABRTQ K9. LK8 PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS Q9U PUEGO 5PM |
ID | FETCH-LOGICAL-c578t-80ebb12fc2f60317ceb01eb2239ad73d3654a87a6fec62155ddb09ba506b5c3d3 |
IEDL.DBID | 7X7 |
ISSN | 0893-133X |
IngestDate | Thu Aug 21 14:10:49 EDT 2025 Fri Sep 05 07:57:40 EDT 2025 Fri Jul 25 09:12:55 EDT 2025 Thu Apr 03 07:06:22 EDT 2025 Sun Jul 06 05:08:45 EDT 2025 Thu Apr 24 23:09:46 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c578t-80ebb12fc2f60317ceb01eb2239ad73d3654a87a6fec62155ddb09ba506b5c3d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://www.nature.com/articles/npp201599.pdf |
PMID | 25865928 |
PQID | 1710988011 |
PQPubID | 33935 |
PageCount | 10 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4569960 proquest_miscellaneous_1722167300 proquest_journals_1710988011 pubmed_primary_25865928 crossref_citationtrail_10_1038_npp_2015_99 crossref_primary_10_1038_npp_2015_99 |
PublicationCentury | 2000 |
PublicationDate | 2015-10-01 |
PublicationDateYYYYMMDD | 2015-10-01 |
PublicationDate_xml | – month: 10 year: 2015 text: 2015-10-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: New York |
PublicationTitle | Neuropsychopharmacology (New York, N.Y.) |
PublicationTitleAlternate | Neuropsychopharmacology |
PublicationYear | 2015 |
Publisher | Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group |
References | EC Beattie (BFnpp201599_CR6) 2000; 3 M Schwendt (BFnpp201599_CR37) 2012; 7 GR Barker (BFnpp201599_CR4) 2011; 31 CM Reichel (BFnpp201599_CR34) 2010; 210 GR Barker (BFnpp201599_CR3) 2008; 28 YS Lee (BFnpp201599_CR19) 2009; 10 M Martin (BFnpp201599_CR23) 2006; 9 PV Massey (BFnpp201599_CR25) 2008; 28 LA Knackstedt (BFnpp201599_CR17) 2014; 19 PV Massey (BFnpp201599_CR24) 2004; 24 G Fischer (BFnpp201599_CR11) 1997; 283 Z Ziakopoulos (BFnpp201599_CR44) 1999; 92 UD McCann (BFnpp201599_CR26) 2008; 62 BP Staresina (BFnpp201599_CR40) 2012; 15 AC Dean (BFnpp201599_CR9) 2013; 38 MM Albasser (BFnpp201599_CR1) 2009; 123 A Ennaceur (BFnpp201599_CR10) 2010; 215 K Cho (BFnpp201599_CR8) 2000; 3 CC Huang (BFnpp201599_CR15) 2011; 31 YM Kupchik (BFnpp201599_CR18) 2012; 71 K Moussawi (BFnpp201599_CR28) 2009; 12 JC Scott (BFnpp201599_CR38) 2007; 17 CM Reichel (BFnpp201599_CR31) 2014; 134 CM Reichel (BFnpp201599_CR32) 2012; 62 S Griffiths (BFnpp201599_CR12) 2008; 58 M Pihlajamaki (BFnpp201599_CR30) 2003; 13 MW Brown (BFnpp201599_CR7) 2001; 2 S Wood (BFnpp201599_CR43) 2014; 66 H Trantham-Davidson (BFnpp201599_CR41) 2014; 34 CL Hart (BFnpp201599_CR13) 2012; 37 L Malkova (BFnpp201599_CR20) 2015; 35 AL Barth (BFnpp201599_CR5) 2008; 58 SL Simon (BFnpp201599_CR39) 2004; 27 GR Barker (BFnpp201599_CR2) 2007; 27 D Montaldi (BFnpp201599_CR27) 2006; 16 JL Rogers (BFnpp201599_CR35) 2008; 199 R Salo (BFnpp201599_CR36) 2009; 37 AH Hawasli (BFnpp201599_CR14) 2007; 10 CM Reichel (BFnpp201599_CR33) 2011; 36 LM Mao (BFnpp201599_CR21) 2009; 12 EC Warburton (BFnpp201599_CR42) 2013; 74 J Kealy (BFnpp201599_CR16) 2011; 93 JF Marshall (BFnpp201599_CR22) 2012; 35 RA O'Neill (BFnpp201599_CR29) 2006; 103 24344115 - Pharmacol Rev. 2014;66(1):193-221 23710649 - Addict Biol. 2014 Jan;19(1):87-101 10649570 - Nat Neurosci. 2000 Feb;3(2):150-6 15223095 - J Subst Abuse Treat. 2004 Jul;27(1):59-66 20060020 - Behav Brain Res. 2010 Dec 31;215(2):244-54 11253359 - Nat Rev Neurosci. 2001 Jan;2(1):51-61 17992686 - Synapse. 2008 Feb;62(2):91-100 19349975 - Nat Neurosci. 2009 May;12(5):602-10 21411660 - J Neurosci. 2011 Mar 16;31(11):4194-203 21150906 - Neuropsychopharmacology. 2011 Mar;36(4):782-92 22709631 - Trends Neurosci. 2012 Sep;35(9):536-45 10408597 - Neuroscience. 1999;92(2):459-72 17053065 - Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16153-8 21775615 - J Neurosci. 2011 Jul 20;31(29):10721-31 15356193 - J Neurosci. 2004 Sep 8;24(36):7821-8 18650332 - J Neurosci. 2008 Jul 23;28(30):7548-54 19339145 - J Subst Abuse Treat. 2009 Oct;37(3):292-7 18439404 - Neuron. 2008 Apr 24;58(2):186-94 19170436 - Behav Neurosci. 2009 Feb;123(1):115-24 16634088 - Hippocampus. 2006;16(5):504-20 22479593 - PLoS One. 2012;7(3):e34299 18337414 - J Neurosci. 2008 Mar 12;28(11):2837-44 17694436 - Neuropsychol Rev. 2007 Sep;17(3):275-97 22751037 - Nat Neurosci. 2012 Aug;15(8):1167-73 25810533 - J Neurosci. 2015 Mar 25;35(12):5043-50 24599469 - J Neurosci. 2014 Mar 5;34(10):3706-18 19136971 - Nat Neurosci. 2009 Feb;12(2):182-9 20352413 - Psychopharmacology (Berl). 2010 Jun;210(3):337-46 17360918 - J Neurosci. 2007 Mar 14;27(11):2948-57 18493748 - Psychopharmacology (Berl). 2008 Sep;199(4):615-24 22115899 - Neuropharmacology. 2012 Feb;62(2):1119-26 21420466 - Prog Neurobiol. 2011 Apr;93(4):522-48 22089317 - Neuropsychopharmacology. 2012 Feb;37(3):586-608 22948978 - Neuropsychopharmacology. 2013 Jan;38(2):259-74 12625459 - Hippocampus. 2003;13(1):67-80 9400004 - J Pharmacol Exp Ther. 1997 Dec;283(3):1285-92 19153576 - Nat Rev Neurosci. 2009 Feb;10(2):126-40 16732275 - Nat Neurosci. 2006 Jul;9(7):868-9 18439398 - Neuron. 2008 Apr 24;58(2):159-61 24120858 - Drug Alcohol Depend. 2014 Jan 1;134:115-22 11100150 - Nat Neurosci. 2000 Dec;3(12):1291-300 17529984 - Nat Neurosci. 2007 Jul;10(7):880-6 22137594 - Biol Psychiatry. 2012 Jun 1;71(11):978-86 23665343 - Neuropharmacology. 2013 Nov;74:41-7 |
References_xml | – volume: 71 start-page: 978 year: 2012 ident: BFnpp201599_CR18 publication-title: Biol Psychiatry doi: 10.1016/j.biopsych.2011.10.024 – volume: 210 start-page: 337 year: 2010 ident: BFnpp201599_CR34 publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-010-1828-5 – volume: 9 start-page: 868 year: 2006 ident: BFnpp201599_CR23 publication-title: Nat Neurosci doi: 10.1038/nn1713 – volume: 74 start-page: 41 year: 2013 ident: BFnpp201599_CR42 publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2013.04.013 – volume: 103 start-page: 16153 year: 2006 ident: BFnpp201599_CR29 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0607973103 – volume: 37 start-page: 586 year: 2012 ident: BFnpp201599_CR13 publication-title: Neuropsychopharmacology doi: 10.1038/npp.2011.276 – volume: 15 start-page: 1167 year: 2012 ident: BFnpp201599_CR40 publication-title: Nat Neurosci doi: 10.1038/nn.3154 – volume: 27 start-page: 2948 year: 2007 ident: BFnpp201599_CR2 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.5289-06.2007 – volume: 38 start-page: 259 year: 2013 ident: BFnpp201599_CR9 publication-title: Neuropsychopharmacology doi: 10.1038/npp.2012.179 – volume: 3 start-page: 1291 year: 2000 ident: BFnpp201599_CR6 publication-title: Nat Neurosci doi: 10.1038/81823 – volume: 215 start-page: 244 year: 2010 ident: BFnpp201599_CR10 publication-title: Behav Brain Res doi: 10.1016/j.bbr.2009.12.036 – volume: 283 start-page: 1285 year: 1997 ident: BFnpp201599_CR11 publication-title: J Pharmacol Exp Ther doi: 10.1016/S0022-3565(24)37138-1 – volume: 37 start-page: 292 year: 2009 ident: BFnpp201599_CR36 publication-title: J Subst Abuse Treat doi: 10.1016/j.jsat.2009.03.004 – volume: 58 start-page: 159 year: 2008 ident: BFnpp201599_CR5 publication-title: Neuron doi: 10.1016/j.neuron.2008.04.006 – volume: 28 start-page: 2837 year: 2008 ident: BFnpp201599_CR3 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.4447-07.2008 – volume: 58 start-page: 186 year: 2008 ident: BFnpp201599_CR12 publication-title: Neuron doi: 10.1016/j.neuron.2008.02.022 – volume: 10 start-page: 126 year: 2009 ident: BFnpp201599_CR19 publication-title: Nat Rev Neurosci doi: 10.1038/nrn2572 – volume: 2 start-page: 51 year: 2001 ident: BFnpp201599_CR7 publication-title: Nat Rev Neurosci doi: 10.1038/35049064 – volume: 3 start-page: 150 year: 2000 ident: BFnpp201599_CR8 publication-title: Nat Neurosci doi: 10.1038/72093 – volume: 10 start-page: 880 year: 2007 ident: BFnpp201599_CR14 publication-title: Nat Neurosci doi: 10.1038/nn1914 – volume: 12 start-page: 182 year: 2009 ident: BFnpp201599_CR28 publication-title: Nat Neurosci doi: 10.1038/nn.2250 – volume: 16 start-page: 504 year: 2006 ident: BFnpp201599_CR27 publication-title: Hippocampus doi: 10.1002/hipo.20178 – volume: 34 start-page: 3706 year: 2014 ident: BFnpp201599_CR41 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.0623-13.2014 – volume: 24 start-page: 7821 year: 2004 ident: BFnpp201599_CR24 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.1697-04.2004 – volume: 28 start-page: 7548 year: 2008 ident: BFnpp201599_CR25 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.1935-08.2008 – volume: 31 start-page: 10721 year: 2011 ident: BFnpp201599_CR4 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.6413-10.2011 – volume: 13 start-page: 67 year: 2003 ident: BFnpp201599_CR30 publication-title: Hippocampus doi: 10.1002/hipo.10049 – volume: 35 start-page: 5043 year: 2015 ident: BFnpp201599_CR20 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.4307-14.2015 – volume: 123 start-page: 115 year: 2009 ident: BFnpp201599_CR1 publication-title: Behav Neurosci doi: 10.1037/a0013829 – volume: 17 start-page: 275 year: 2007 ident: BFnpp201599_CR38 publication-title: Neuropsychol Rev doi: 10.1007/s11065-007-9031-0 – volume: 12 start-page: 602 year: 2009 ident: BFnpp201599_CR21 publication-title: Nat Neurosci doi: 10.1038/nn.2300 – volume: 19 start-page: 87 year: 2014 ident: BFnpp201599_CR17 publication-title: Addict Biol doi: 10.1111/adb.12061 – volume: 199 start-page: 615 year: 2008 ident: BFnpp201599_CR35 publication-title: Psychopharmacology (Berl) doi: 10.1007/s00213-008-1187-7 – volume: 92 start-page: 459 year: 1999 ident: BFnpp201599_CR44 publication-title: Neuroscience doi: 10.1016/S0306-4522(98)00764-7 – volume: 7 start-page: e34299 year: 2012 ident: BFnpp201599_CR37 publication-title: PLoS One doi: 10.1371/journal.pone.0034299 – volume: 93 start-page: 522 year: 2011 ident: BFnpp201599_CR16 publication-title: Prog Neurobiol doi: 10.1016/j.pneurobio.2011.03.002 – volume: 35 start-page: 536 year: 2012 ident: BFnpp201599_CR22 publication-title: Trends in neurosciences doi: 10.1016/j.tins.2012.05.006 – volume: 62 start-page: 91 year: 2008 ident: BFnpp201599_CR26 publication-title: Synapse doi: 10.1002/syn.20471 – volume: 27 start-page: 59 year: 2004 ident: BFnpp201599_CR39 publication-title: J Subst Abuse Treat doi: 10.1016/j.jsat.2004.03.011 – volume: 31 start-page: 4194 year: 2011 ident: BFnpp201599_CR15 publication-title: J Neurosci doi: 10.1523/JNEUROSCI.5239-10.2011 – volume: 134 start-page: 115 year: 2014 ident: BFnpp201599_CR31 publication-title: Drug Alcohol Depend doi: 10.1016/j.drugalcdep.2013.09.018 – volume: 62 start-page: 1119 year: 2012 ident: BFnpp201599_CR32 publication-title: Neuropharmacology doi: 10.1016/j.neuropharm.2011.11.003 – volume: 36 start-page: 782 year: 2011 ident: BFnpp201599_CR33 publication-title: Neuropsychopharmacology doi: 10.1038/npp.2010.212 – volume: 66 start-page: 193 year: 2014 ident: BFnpp201599_CR43 publication-title: Pharmacol Rev doi: 10.1124/pr.112.007054 – reference: 17529984 - Nat Neurosci. 2007 Jul;10(7):880-6 – reference: 19339145 - J Subst Abuse Treat. 2009 Oct;37(3):292-7 – reference: 23665343 - Neuropharmacology. 2013 Nov;74:41-7 – reference: 18439404 - Neuron. 2008 Apr 24;58(2):186-94 – reference: 21420466 - Prog Neurobiol. 2011 Apr;93(4):522-48 – reference: 18337414 - J Neurosci. 2008 Mar 12;28(11):2837-44 – reference: 19136971 - Nat Neurosci. 2009 Feb;12(2):182-9 – reference: 15223095 - J Subst Abuse Treat. 2004 Jul;27(1):59-66 – reference: 17694436 - Neuropsychol Rev. 2007 Sep;17(3):275-97 – reference: 22709631 - Trends Neurosci. 2012 Sep;35(9):536-45 – reference: 19153576 - Nat Rev Neurosci. 2009 Feb;10(2):126-40 – reference: 22948978 - Neuropsychopharmacology. 2013 Jan;38(2):259-74 – reference: 20352413 - Psychopharmacology (Berl). 2010 Jun;210(3):337-46 – reference: 24120858 - Drug Alcohol Depend. 2014 Jan 1;134:115-22 – reference: 22137594 - Biol Psychiatry. 2012 Jun 1;71(11):978-86 – reference: 17992686 - Synapse. 2008 Feb;62(2):91-100 – reference: 23710649 - Addict Biol. 2014 Jan;19(1):87-101 – reference: 19170436 - Behav Neurosci. 2009 Feb;123(1):115-24 – reference: 18493748 - Psychopharmacology (Berl). 2008 Sep;199(4):615-24 – reference: 22479593 - PLoS One. 2012;7(3):e34299 – reference: 21150906 - Neuropsychopharmacology. 2011 Mar;36(4):782-92 – reference: 20060020 - Behav Brain Res. 2010 Dec 31;215(2):244-54 – reference: 18650332 - J Neurosci. 2008 Jul 23;28(30):7548-54 – reference: 10649570 - Nat Neurosci. 2000 Feb;3(2):150-6 – reference: 12625459 - Hippocampus. 2003;13(1):67-80 – reference: 22089317 - Neuropsychopharmacology. 2012 Feb;37(3):586-608 – reference: 24599469 - J Neurosci. 2014 Mar 5;34(10):3706-18 – reference: 15356193 - J Neurosci. 2004 Sep 8;24(36):7821-8 – reference: 9400004 - J Pharmacol Exp Ther. 1997 Dec;283(3):1285-92 – reference: 18439398 - Neuron. 2008 Apr 24;58(2):159-61 – reference: 21411660 - J Neurosci. 2011 Mar 16;31(11):4194-203 – reference: 22115899 - Neuropharmacology. 2012 Feb;62(2):1119-26 – reference: 11253359 - Nat Rev Neurosci. 2001 Jan;2(1):51-61 – reference: 19349975 - Nat Neurosci. 2009 May;12(5):602-10 – reference: 25810533 - J Neurosci. 2015 Mar 25;35(12):5043-50 – reference: 17360918 - J Neurosci. 2007 Mar 14;27(11):2948-57 – reference: 16732275 - Nat Neurosci. 2006 Jul;9(7):868-9 – reference: 17053065 - Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16153-8 – reference: 21775615 - J Neurosci. 2011 Jul 20;31(29):10721-31 – reference: 11100150 - Nat Neurosci. 2000 Dec;3(12):1291-300 – reference: 10408597 - Neuroscience. 1999;92(2):459-72 – reference: 16634088 - Hippocampus. 2006;16(5):504-20 – reference: 22751037 - Nat Neurosci. 2012 Aug;15(8):1167-73 – reference: 24344115 - Pharmacol Rev. 2014;66(1):193-221 |
SSID | ssj0015768 |
Score | 2.2940924 |
Snippet | Exposure to methamphetamine (meth) can produce lasting memory impairments in humans and rodents. We recently demonstrated that extended access meth... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 2526 |
SubjectTerms | Abstinence Addictions Amphetamine-Related Disorders - drug therapy Amphetamine-Related Disorders - physiopathology Animals Central Nervous System Stimulants - administration & dosage Cognitive ability Cycloserine - pharmacology Excitatory Amino Acid Agents - pharmacology Laboratory animals Long-Term Synaptic Depression - drug effects Long-Term Synaptic Depression - physiology Male Memory Memory Disorders - chemically induced Memory Disorders - physiopathology Methamphetamine Methamphetamine - administration & dosage Neurosciences Original Phenols - pharmacology Physiology Piperidines - pharmacology Rats, Sprague-Dawley Receptors, N-Methyl-D-Aspartate - agonists Receptors, N-Methyl-D-Aspartate - antagonists & inhibitors Receptors, N-Methyl-D-Aspartate - metabolism Recognition (Psychology) - drug effects Recognition (Psychology) - physiology Self Administration Tissue Culture Techniques |
Title | Failure to Recognize Novelty after Extended Methamphetamine Self-Administration Results from Loss of Long-Term Depression in the Perirhinal Cortex |
URI | https://www.ncbi.nlm.nih.gov/pubmed/25865928 https://www.proquest.com/docview/1710988011 https://www.proquest.com/docview/1722167300 https://pubmed.ncbi.nlm.nih.gov/PMC4569960 |
Volume | 40 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1db9MwFLVgkxAvCDo-AmMy0rQHNLM433lCY7SaEK2q0Ul9i-zYZpUypywpovwMfjHXjputgHhpH-wmqe69uce-x-cidKhizlMVRkQIEZAIcizJMiZICJ8qpipKraTQeJKcX0af5vHcbbg1jla5eSfaF7WoS7NHfkINaRCcjdL3y2_EdI0y1VXXQuM-2rXSZeDP6bxfcFGDpS2KzEMCa7G5O5_nh9mJXhqxShq_s6KvdzLSXzDzT7bknfQzeoweOdyITztDP0H3pB6gvVMNa-brNT7Clslpt8gH6MHYFcwH6GjaSVOvj_Hs9qRVc2x_0YtWr_fQrxFbGIY6bmt80ZGKfko8qb_Lql1j20kcD92GOR7L9oqBG8iWXcNt8BdZKbItwwsXaVZV22BzfgV_hj-OawXf-iuZQTLAHzcMXI0XGgMKxVOIhRvTzbvCZ4YB_OMpuhwNZ2fnxPVrICXEfQvJTnJOA1UGyvSuTkvJfQor9yDMmUhDESZxxLKUJUqWCUCNWAju55zFfsLjEsafoR1da_kCYQU5lAouQ8FFFPg5g0szv-RS0kwAZPTQ243NitKJmZueGlVhi-phVoCBC2PgIs89dNhPXnYaHv-etr8xfuECuSlu3c5Db_phCEFTV2Fa1iszJwhoYoT_PfS885X-PkGcmcJ15qF0y4v6CUbee3tEL66szDdAWyOd8_L_j_UKPTTP3_EL99FOe7OSrwEntfzABsMB2v0wnEwvfgNPyRlB |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB6VVAIuCFIeKQUWqfSAaur344BQaROlNImikkq5ubvedRsptUPjAOFn8EP4jcz41QYQt17sw67XtmZ2Z3bnm28AtmNHCC-2bE1KaWo22ljN97nULLzGjhHbXk4p1B-43VP709gZr8GvKheGYJXVmpgv1DKN6Ix8zyDQICqbYXyYfdGoahRFV6sSGoVaHKvlN9yyzd8fHaJ835hmpz066GplVQEtQu3McElWQhhmHJkxVVj2IiV0A_eXphVw6VnSch2b-x53YxW5aBAdKYUeCO7ornAibMdx78C6TRmtDVj_2B4MT-q4BXnvud8aWBru_sZlRqBu-XvJjOgxDeddTjN7wwb-5dj-ic-8YfA6D-FB6amy_UK1HsGaSpqwsZ_gLv1yyXZYjh3ND-WbcLdfhuibsDMsyLCXu2x0nds1382fqGmylxvws8MnhIlnWcpOChjTD8UG6Vc1zZYsr13O2uURPeur7IKj4qmMX-Jr2Gc1jbVV4l8cZL6YZnNGGTOshz_O0hjvybk2QvPDDivMb8ImCUO_lw1x9l1R_fApOyDM8ffHcHorsnwCjSRN1DNgMVptQwplSSFtUw84Ds31SChl-BKd1Ba8rWQWRiV9OlXxmIZ5GN_yQxRwSAIOg6AF23XnWcEa8u9uW5Xww3LpmIfXit6C13UzTnqK5PBEpQvqY5qGS6UGWvC00JX6PabjU6jcb4G3okV1ByIUX21JJhc5sTg600TWs_n_z3oF97qjfi_sHQ2On8N9-pcC3bgFjexqoV6gl5aJl-XUYHB227PxN5knVrA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LbxMxEB6VIlVcUEl5hBYwUukBdcl633tAqGoatbSJIkil3BZ7bdNI6W5oNkD4Gfwcfh1j76MNIG69JAc73qxmxjPj-fwNwK7yOQ-V61lCCMfy0MdaUcSE5eKn8qnyQkMp1B8Ex-fe-7E_XoNf9V0YDaus90SzUYs81WfkHapBg6hslHZUBYsYdnvvZl8s3UFKV1rrdhqlipzK5TdM3-ZvT7oo61eO0zsaHR5bVYcBK0VNLXB7lpxTR6WO0t2Ww1Rym2Ku6bgxE6Er3MD3WBSyQMk0QOfoC8HtmDPfDrif4jiuewfuhi5GVWhL4bhJ9qiO400EG7sW5oHj6m6g7UadbKaJMqn_xhDO3vCGf4W4fyI1b7i-3ibcr2JWclAq2QNYk1kLtg4yzNcvl2SPGBSpOZ5vwUa_Kta3YG9Y0mIv98no-pbXfN_8oiHMXm7Bzx6baHQ8KXLyoQQ0_ZBkkH-V02JJTBdzclQd1pO-LC4YqqAs2CU-hnyUU2WtUgDjIvPFtJgTfXeGnOGLk1zhd_bZGqEjIt0a_ZuRSUYwAiZDtMMr3Ul8Sg41-vj7Qzi_FUk-gvUsz-QTIAr9NxVcuoILz7FjhkszO-VS0khguNqG17XMkrQiUtf9PKaJKei7UYICTrSAkzhuw24zeVbyh_x72k4t_KTaRObJtcq34WUzjOavazosk_lCz3EcGuimA214XOpK8xzHj3TRPGpDuKJFzQRNLb46kk0uDMU4htWatufp___WC9hAG0zOTgan23BPv0oJc9yB9eJqIZ9huFbw58YuCHy6bUP8DUfzWXc |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Failure+to+Recognize+Novelty+after+Extended+Methamphetamine+Self-Administration+Results+from+Loss+of+Long-Term+Depression+in+the+Perirhinal+Cortex&rft.jtitle=Neuropsychopharmacology+%28New+York%2C+N.Y.%29&rft.au=Scofield%2C+Michael+D&rft.au=Trantham-Davidson%2C+Heather&rft.au=Schwendt%2C+Marek&rft.au=Leong%2C+Kah-Chung&rft.date=2015-10-01&rft.issn=0893-133X&rft.eissn=1740-634X&rft.volume=40&rft.issue=11&rft.spage=2526&rft.epage=2535&rft_id=info:doi/10.1038%2Fnpp.2015.99&rft.externalDBID=n%2Fa&rft.externalDocID=10_1038_npp_2015_99 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0893-133X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0893-133X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0893-133X&client=summon |